Search Results

Press Releases

electroCore to Participate at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum on November 21

November 14, 2024

·

1 min read

Press Releases

electroCore Announces Inducement Grant under NASDAQ Listing Rule 5635(c)(4) - November 8, 2024

November 11, 2024

·

1 min read

Pharm Country

electroCore Announces the Commercial Launch of TAC-STIM™Upgraded TAC-STIM enhances Energy, Focus and Readiness

electroCore, Inc. is thrilled to announce the Commercial Off the Shelf (COTS) availability of the next generation TAC-STIM™, a non-invasive vagus nerve stimulator (nVNS) designed in partnership with the US military to enhance human performance exclusively for active-duty military use.

June 25, 2024

·

4 min read

Pharm Country

electroCore to Participate in Upcoming Investor Conferences

electroCore, Inc. announced today that the Company’s Chief Strategy Officer, Joshua Lev, is scheduled to attend the 36th Annual Roth Conference taking place at The Ritz Carlton Laguna Niguel in Dana Point, California on March 17 – 19, 2024.

March 12, 2024

·

1 min read

Deals

electroCore, Inc. Announces Closing of $9.3 Million Registered Direct Offering and Concurrent Private Placements Priced At Market Under Nasdaq Rules

electroCore, Inc. today announced the closing of its previously announced registered direct offering of 225,000 registered pre-funded warrants to purchase shares of common stock.

June 6, 2024

·

6 min read

Business

electroCore to Announce First Quarter March 31, 2024 Financial Results on Wednesday, May 8, 2024

electroCore, Inc. today announced that it will report financial results for the first quarter ended March 31, 2024, after the close of the market on Wednesday, May 8, 2024.

May 1, 2024

·

1 min read

Business

electroCore Announces Second Quarter 2024 Financial Results

August 7, 2024

·

10 min read

Business

electroCore Announces Fourth Quarter and Full Year 2023 Financial Results

electroCore, Inc. (Nasdaq: ECOR) (the “Company”), a commercial-stage bioelectronic medicine and wellness company, today announced fourth quarter and full year 2023 financial results.

March 13, 2024

·

10 min read

Deals

electroCore, Inc. Announces $9.3 Million Registered Direct Offering and Concurrent Private Placements Priced At Market Under Nasdaq Rules

electroCore, Inc. today announced that it has agreed to issue and sell to an institutional accredited investor an aggregate of 225,000 registered pre-funded warrants to purchase shares of common stock and unregistered warrants to purchase up to an aggregate of 112,500 shares of common stock.

June 3, 2024

·

6 min read

Pharm Country

electroCore Expands Intellectual Property PortfolioelectroCore Granted Two New U.S. Patents

electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that it has received patent issue notifications from the United States Patent and Trademark Office (USPTO).

April 2, 2024

·

3 min read